GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Chr. Hansen Holding A/S (OCSE:CHR) » Definitions » EV-to-EBIT

Chr. Hansen Holding A/S (OCSE:CHR) EV-to-EBIT : 34.20 (As of May. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chr. Hansen Holding A/S EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chr. Hansen Holding A/S's Enterprise Value is kr80,104 Mil. Chr. Hansen Holding A/S's EBIT for the trailing twelve months (TTM) ended in May. 2023 was kr2,342 Mil. Therefore, Chr. Hansen Holding A/S's EV-to-EBIT for today is 34.20.

The historical rank and industry rank for Chr. Hansen Holding A/S's EV-to-EBIT or its related term are showing as below:

OCSE:CHR' s EV-to-EBIT Range Over the Past 10 Years
Min: 20.66   Med: 32.67   Max: 46.68
Current: 34.2

During the past 13 years, the highest EV-to-EBIT of Chr. Hansen Holding A/S was 46.68. The lowest was 20.66. And the median was 32.67.

OCSE:CHR's EV-to-EBIT is not ranked
in the Chemicals industry.
Industry Median: 17.23 vs OCSE:CHR: 34.20

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Chr. Hansen Holding A/S's Enterprise Value for the quarter that ended in May. 2023 was kr73,102 Mil. Chr. Hansen Holding A/S's EBIT for the trailing twelve months (TTM) ended in May. 2023 was kr2,342 Mil. Chr. Hansen Holding A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2023 was 3.20%.


Chr. Hansen Holding A/S EV-to-EBIT Historical Data

The historical data trend for Chr. Hansen Holding A/S's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chr. Hansen Holding A/S EV-to-EBIT Chart

Chr. Hansen Holding A/S Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.93 34.77 45.29 41.83 28.09

Chr. Hansen Holding A/S Quarterly Data
Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.74 28.09 27.98 30.45 31.21

Competitive Comparison of Chr. Hansen Holding A/S's EV-to-EBIT

For the Specialty Chemicals subindustry, Chr. Hansen Holding A/S's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chr. Hansen Holding A/S's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Chr. Hansen Holding A/S's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Chr. Hansen Holding A/S's EV-to-EBIT falls into.



Chr. Hansen Holding A/S EV-to-EBIT Calculation

Chr. Hansen Holding A/S's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=80104.011/2342.316
=34.20

Chr. Hansen Holding A/S's current Enterprise Value is kr80,104 Mil.
Chr. Hansen Holding A/S's EBIT for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2,342 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chr. Hansen Holding A/S  (OCSE:CHR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Chr. Hansen Holding A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: May. 2023 ) =EBIT / Enterprise Value (Q: May. 2023 )
=2342.316/73102.0344
=3.20 %

Chr. Hansen Holding A/S's Enterprise Value for the quarter that ended in May. 2023 was kr73,102 Mil.
Chr. Hansen Holding A/S's EBIT for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2,342 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chr. Hansen Holding A/S EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Chr. Hansen Holding A/S's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Chr. Hansen Holding A/S (OCSE:CHR) Business Description

Traded in Other Exchanges
Address
Boge Alle 10-12, Horsholm, DNK, 2970
Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company with more than 3,200 employees across 30 countries. Its segments include food cultures and enzymes that produce and sell innovative cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf-life, nutritional value, and health benefits of a variety of consumer products in the food industry, especially in the dairy industry; and health and nutrition that produce and sell products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries.